300633 开立医疗
交易中 05-13 14:53:51
资讯
新帖
简况
开立医疗（300633）披露回购股份比例达到公司总股本1%暨回购进展公告，5月7日股价上涨0.54%
中金财经 · 05-07
开立医疗（300633）披露回购股份比例达到公司总股本1%暨回购进展公告，5月7日股价上涨0.54%
【机构调研记录】博远基金调研尚品宅配、开立医疗等4只个股（附名单）
证券之星 · 04-30
【机构调研记录】博远基金调研尚品宅配、开立医疗等4只个股（附名单）
4月29日开立医疗跌5.26%，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 04-29
4月29日开立医疗跌5.26%，融通健康产业灵活配置混合A/B基金重仓该股
开立医疗(300633.SZ)发布一季度业绩，由盈转亏至1160.94万元
智通财经 · 04-28
开立医疗(300633.SZ)发布一季度业绩，由盈转亏至1160.94万元
图解开立医疗一季报：第一季度单季净利润同比下降243.78%
证券之星 · 04-28
图解开立医疗一季报：第一季度单季净利润同比下降243.78%
股市必读：开立医疗（300633）4月24日披露最新机构调研信息
证券之星 · 04-27
股市必读：开立医疗（300633）4月24日披露最新机构调研信息
【机构调研记录】易米基金调研开立医疗
证券之星 · 04-27
【机构调研记录】易米基金调研开立医疗
开立医疗：公司微创外科业务最近几年连续快速增长
证券之星 · 04-20
开立医疗：公司微创外科业务最近几年连续快速增长
开立医疗（300633）2025年年报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 04-18
开立医疗（300633）2025年年报简析：营收净利润同比双双增长，应收账款上升
开立医疗（300633）披露2025年年度报告，4月17日股价上涨3.3%
证券之星 · 04-17
开立医疗（300633）披露2025年年度报告，4月17日股价上涨3.3%
开立医疗(300633.SZ)发布2025年度业绩，归母净利润1.97亿元，增长38.54%
智通财经网 · 04-16
开立医疗(300633.SZ)发布2025年度业绩，归母净利润1.97亿元，增长38.54%
开立医疗新注册《开立UD0058D1系列彩色超声多普勒系统软件V1.0》项目的软件著作权
证券之星 · 04-11
开立医疗新注册《开立UD0058D1系列彩色超声多普勒系统软件V1.0》项目的软件著作权
开立医疗（300633）披露回购股份用于注销并减少注册资本公告，4月7日股价上涨0.16%
证券之星 · 04-07
开立医疗（300633）披露回购股份用于注销并减少注册资本公告，4月7日股价上涨0.16%
开立医疗拟斥资1亿元至2亿元回购，用于注销并减少注册资本
财中社 · 04-03
开立医疗拟斥资1亿元至2亿元回购，用于注销并减少注册资本
开立医疗：公司已发布回购股份并注销的方案
证券之星 · 04-01
开立医疗：公司已发布回购股份并注销的方案
开立医疗新注册《开立内窥镜摄像系统电子内窥镜成像软件V1.0》项目的软件著作权
证券之星 · 03-28
开立医疗新注册《开立内窥镜摄像系统电子内窥镜成像软件V1.0》项目的软件著作权
开立医疗新注册《开立181202系列医用内窥镜摄像系统软件V2.0》项目的软件著作权
证券之星 · 03-27
开立医疗新注册《开立181202系列医用内窥镜摄像系统软件V2.0》项目的软件著作权
开立医疗新注册《开立内窥镜超高清系统电子内窥镜成像软件V1.0》等2个项目的软件著作权
证券之星 · 03-25
开立医疗新注册《开立内窥镜超高清系统电子内窥镜成像软件V1.0》等2个项目的软件著作权
开立医疗最新公告：取得不超过1.8亿元股票回购专项贷款承诺函
证券之星 · 03-20
开立医疗最新公告：取得不超过1.8亿元股票回购专项贷款承诺函
3月20日开立医疗创60日新低，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 03-20
3月20日开立医疗创60日新低，融通健康产业灵活配置混合A/B基金重仓该股
加载更多
公司概况
公司名称：
深圳开立生物医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2017-04-06
主营业务：
深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是超声诊断仪、消化与呼吸内镜、微创外科产品、心血管介入产品。
发行价格：
5.23
{"stockData":{"symbol":"300633","market":"SZ","secType":"STK","nameCN":"开立医疗","latestPrice":23.91,"timestamp":1778655231000,"preClose":23.49,"halted":0,"volume":5368918,"delay":0,"changeRate":0.0179,"floatShares":268000000,"shares":433000000,"eps":0.4105,"marketStatus":"交易中","change":0.42,"latestTime":"05-13 14:53:51","open":23.45,"high":24.23,"low":23.45,"amount":129000000,"amplitude":0.0332,"askPrice":23.94,"askSize":27,"bidPrice":23.91,"bidSize":71,"shortable":0,"etf":0,"ttmEps":0.4105,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778655600000},"marketStatusCode":2,"adr":0,"adjPreClose":23.49,"symbolType":"stock","openAndCloseTimeList":[[1778635800000,1778643000000],[1778648400000,1778655600000]],"highLimit":25.84,"lowLimit":21.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":432712405,"isCdr":false,"pbRate":3.11,"roa":"--","peRate":58.246041,"roe":"--","epsLYR":0.46,"committee":0.279461,"marketValue":10346000000,"turnoverRate":0.02,"status":0,"floatMarketCap":6408000000},"requestUrl":"/m/hq/s/300633","defaultTab":"news","newsList":[{"id":"2633112948","title":"开立医疗（300633）披露回购股份比例达到公司总股本1%暨回购进展公告，5月7日股价上涨0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633112948","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633112948?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:54","pubTimestamp":1778147686,"startTime":"0","endTime":"0","summary":"近日，开立医疗发布《关于回购股份比例达到公司总股本1%暨回购进展的公告》。公告显示，公司于2026年3月17日召开董事会、4月3日召开临时股东会，审议通过回购股份方案。截至2026年4月30日，已回购股份6,658,600股，占公司总股本的1.54%，最高成交价28.15元/股，最低成交价23.35元/股，成交金额170,945,668.16元。本次回购符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260507/32206763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["SG9999001051.SGD","300633","BK0251","SG9999001069.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575491","title":"【机构调研记录】博远基金调研尚品宅配、开立医疗等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631575491?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:05","pubTimestamp":1777507554,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月29日披露的机构调研信息，博远基金近期对4家上市公司进行了调研，相关名单如下：1）尚品宅配 调研纪要：2025年公司实现营业收入35.52亿元，2026年第一季度实现营业收入5.98亿元。2026年一季度营业收入22.21亿元，同比增长64.19%；归母净利润7.81亿元，同比增长50.65%。2025年度拟现金分红2.12亿元，近三年累计分红10.64亿元；2025年注销回购股份约2亿元视同现金分红。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000028086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0260","300633","BK0197","SG9999001069.SGD","300616","SG9999006597.SGD","BK0251","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631056068","title":"4月29日开立医疗跌5.26%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631056068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631056068?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:38","pubTimestamp":1777451926,"startTime":"0","endTime":"0","summary":"证券之星消息，4月29日开立医疗跌5.26%，收盘报24.3元，换手率5.28%，成交量14.15万手，成交额3.43亿元。重仓开立医疗的前十大公募基金请见下表：该股最近90天内共有12家机构给出评级，买入评级10家，增持评级2家；过去90天内机构目标均价为36.08。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。该公募基金现任基金经理为万民远。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900052336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","BK0251","SG9999006597.SGD","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630119303","title":"开立医疗(300633.SZ)发布一季度业绩，由盈转亏至1160.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630119303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630119303?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:58","pubTimestamp":1777373906,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开立医疗(300633.SZ)发布2026年第一季度报告，该公司营业收入为4.81亿元，同比增长11.79%。归属于上市公司股东的净亏损为1160.94万元。归属于上市公司股东的扣除非经常性损益的净亏损为1429.01万元。基本每股亏损为0.0268元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999001069.SGD","BK0251","SG9999001051.SGD","300633","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630626370","title":"图解开立医疗一季报：第一季度单季净利润同比下降243.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630626370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630626370?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:24","pubTimestamp":1777371896,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗2026年一季报显示，一季度公司主营收入4.81亿元，同比上升11.79%；归母净利润-1160.94万元，同比下降243.78%；扣非净利润-1429.01万元，同比下降338.24%；负债率24.09%，投资收益26.15万元，财务费用2094.17万元，毛利率61.44%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800054380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630333752","title":"股市必读：开立医疗（300633）4月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2630333752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630333752?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:28","pubTimestamp":1777249690,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，开立医疗报收于26.87元，下跌2.75%，换手率2.09%，成交量5.59万手，成交额1.51亿元。2025年研发投入4.96亿元，占营收比重21.47%，研发费用率同比下降2.01个百分点；销售费用6.75亿元，占营收比重29.26%，销售费用率同比上升0.81个百分点，主因新产品线投入增加。2026年公司将加强费用管控，随收入增长，预计研发与销售费用率将逐步下降，净利润率有望回升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","SG9999006597.SGD","SG9999001051.SGD","300633","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630324223","title":"【机构调研记录】易米基金调研开立医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2630324223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630324223?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:02","pubTimestamp":1777248169,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月24日披露的机构调研信息，易米基金近期对1家上市公司进行了调研，相关名单如下：1）开立医疗 调研纪要：2025年公司营业收入23.09亿，同比增长14.65%；超声持平，消化内镜、微创外科增长超30%，IVUS增长超200%；国内、国际业务收入各约11.7亿和11.4亿，占比均50%左右。旗下最近一年表现最佳的公募基金产品为易米远见价值一年定开混合A，最新单位净值为1.74，近一年增长98.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","SG9999006597.SGD","300633","BK0251","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628028715","title":"开立医疗：公司微创外科业务最近几年连续快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2628028715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628028715?lang=zh_cn&edition=full","pubTime":"2026-04-20 12:09","pubTimestamp":1776658149,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗(300633)04月20日在投资者关系平台上答复投资者关心的问题。投资者提问：公司目前新推出的腔镜系统在外科表现突出，外科整体市场规模也远大于内科，请问公司是否有意愿进一步扩大外科市场的产品规模开立医疗回复：您好，公司微创外科业务最近几年连续快速增长，终端中标金额的行业排名快速提升，预计未来几年公司外科业务仍将保持较好增长态势，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000012729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","300633","SG9999001069.SGD","SG9999001051.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628787766","title":"开立医疗（300633）2025年年报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2628787766","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628787766?lang=zh_cn&edition=full","pubTime":"2026-04-18 06:13","pubTimestamp":1776463990,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期开立医疗发布2025年年报。截至本报告期末，公司营业总收入23.09亿元，同比上升14.65%，归母净利润1.97亿元，同比上升38.54%。本报告期开立医疗应收账款上升，应收账款同比增幅达41.88%。公司 HD-650 系列内镜自 2025 年二季度上市后，临床表现优异，受到国内外专家的广泛好评。2025年公司 650销售超过百台，产品单价、毛利率均较高，带动公司内镜产品线整体毛利率维持高位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800008811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628274631","title":"开立医疗（300633）披露2025年年度报告，4月17日股价上涨3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628274631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628274631?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:17","pubTimestamp":1776417471,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，开立医疗报收于28.19元，较前一交易日上涨3.3%，最新总市值为121.98亿元。该股当日开盘28.65元，最高29.49元，最低28.06元，成交额达7.04亿元，换手率为9.2%。公司于2026年4月17日披露《2025年年度报告》。报告显示，开立医疗2025年实现营业收入2,308,908,666.51元，同比增长14.65%；归属于上市公司股东的净利润为197,280,077.30元，同比增长38.54%；扣除非经常性损益后的净利润为180,275,203.05元，同比增长63.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700032720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999006597.SGD","BK0251","SG9999001069.SGD","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627729767","title":"开立医疗(300633.SZ)发布2025年度业绩，归母净利润1.97亿元，增长38.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627729767","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627729767?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:38","pubTimestamp":1776339485,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开立医疗(300633.SZ)发布2025年年度报告，该公司营业收入为23.09亿元，同比增长14.65%。归属于上市公司股东的净利润为1.97亿元，同比增长38.54%。归属于上市公司股东的扣除非经常性损益的净利润为1.8亿元，同比增长63.41%。基本每股收益为0.46元。此外，拟向全体股东每10股派发现金红利1.8元(含税)。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"开立医疗(300633.SZ)发布2025年度业绩，归母净利润1.97亿元，增长38.54%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626711251","title":"开立医疗新注册《开立UD0058D1系列彩色超声多普勒系统软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2626711251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626711251?lang=zh_cn&edition=full","pubTime":"2026-04-11 01:53","pubTimestamp":1775843590,"startTime":"0","endTime":"0","summary":"证券之星消息，近日开立医疗新注册了《开立UD0058D1系列彩色超声多普勒系统软件V1.0》项目的软件著作权。今年以来开立医疗新注册软件著作权9个，较去年同期减少了40%。通过天眼查大数据分析，深圳开立生物医疗科技股份有限公司共对外投资了12家企业，参与招投标项目2398次；财产线索方面有商标信息408条，专利信息1670条，著作权信息336条；此外企业还拥有行政许可274个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041100001376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999001069.SGD","159180","BK0251","SG9999006597.SGD","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625939002","title":"开立医疗（300633）披露回购股份用于注销并减少注册资本公告，4月7日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625939002","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625939002?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:58","pubTimestamp":1775555897,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，开立医疗报收于25.12元，较前一交易日上涨0.16%，最新总市值为108.7亿元。近日，开立医疗发布《关于回购股份用于注销并减少注册资本暨通知债权人的公告》。公告显示，公司于2026年3月17日召开第四届董事会第十四次会议，并于2026年4月3日召开临时股东会，审议通过回购股份方案。公司拟使用自有或自筹资金，以集中竞价方式回购股份，全部用于注销并减少注册资本。回购实施期限为股东会审议通过之日起12个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","BK0251","SG9999001051.SGD","SG9999001069.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624065265","title":"开立医疗拟斥资1亿元至2亿元回购，用于注销并减少注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2624065265","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624065265?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:42","pubTimestamp":1775212920,"startTime":"0","endTime":"0","summary":"4月3日，开立医疗（300633）发布公告，公司计划自公司股东会审议通过本次回购方案之日起12个月内，以集中竞价方式回购股份，资金总额不低于1亿元且不超过2亿元，回购价格上限为40.32元/股，预计回购股份数量为248万股至496万股，约占总股本的0.57%至1.15%。本次回购的股份将全部用于注销并减少注册资本。 2025年前三季度，开立医疗实现收入14.59亿元，归母净利润3351万元。（文章来源：财中社）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2026-04-03/doc-inhtfkwv7074741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300633","SG9999001069.SGD","BK0251","SG9999006597.SGD","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624516654","title":"开立医疗：公司已发布回购股份并注销的方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2624516654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624516654?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:51","pubTimestamp":1775047871,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗(300633)03月31日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，贵公司经营业绩出现问题了吗，现在大盘4100点，贵公司股价持续下跌，跌到了大盘24年2600点位置，大幅跑输市场平均涨幅，请问贵公司是否有市值管理工作举措？开立医疗回复：您好，公司已发布回购股份并注销的方案，请您查阅，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100040899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","BK0251","SG9999006597.SGD","300633","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622872276","title":"开立医疗新注册《开立内窥镜摄像系统电子内窥镜成像软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622872276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622872276?lang=zh_cn&edition=full","pubTime":"2026-03-28 02:35","pubTimestamp":1774636514,"startTime":"0","endTime":"0","summary":"证券之星消息，近日开立医疗新注册了《开立内窥镜摄像系统电子内窥镜成像软件V1.0》项目的软件著作权。今年以来开立医疗新注册软件著作权8个，较去年同期减少了42.86%。通过天眼查大数据分析，深圳开立生物医疗科技股份有限公司共对外投资了12家企业，参与招投标项目2391次；财产线索方面有商标信息405条，专利信息1631条，著作权信息334条；此外企业还拥有行政许可274个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800005449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","300633","SG9999001069.SGD","SG9999001051.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622889364","title":"开立医疗新注册《开立181202系列医用内窥镜摄像系统软件V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622889364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622889364?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:30","pubTimestamp":1774549835,"startTime":"0","endTime":"0","summary":"证券之星消息，近日开立医疗新注册了《开立181202系列医用内窥镜摄像系统软件V2.0》项目的软件著作权。今年以来开立医疗新注册软件著作权7个，较去年同期减少了50%。通过天眼查大数据分析，深圳开立生物医疗科技股份有限公司共对外投资了12家企业，参与招投标项目2398次；财产线索方面有商标信息405条，专利信息1609条，著作权信息332条；此外企业还拥有行政许可274个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700004283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","SG9999006597.SGD","SG9999001069.SGD","BK0251","300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622811097","title":"开立医疗新注册《开立内窥镜超高清系统电子内窥镜成像软件V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622811097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622811097?lang=zh_cn&edition=full","pubTime":"2026-03-25 02:06","pubTimestamp":1774375582,"startTime":"0","endTime":"0","summary":"证券之星消息，近日开立医疗新注册了2个项目的软件著作权，包括《开立内窥镜超高清系统电子内窥镜成像软件V1.0》、《开立内窥镜高清系统电子内窥镜成像软件V1.0》等。今年以来开立医疗新注册软件著作权6个，较去年同期减少了57.14%。通过天眼查大数据分析，深圳开立生物医疗科技股份有限公司共对外投资了12家企业，参与招投标项目2398次；财产线索方面有商标信息405条，专利信息1609条，著作权信息332条；此外企业还拥有行政许可274个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500003536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","BK0251","SG9999006597.SGD","300633","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620362757","title":"开立医疗最新公告：取得不超过1.8亿元股票回购专项贷款承诺函","url":"https://stock-news.laohu8.com/highlight/detail?id=2620362757","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620362757?lang=zh_cn&edition=full","pubTime":"2026-03-20 20:49","pubTimestamp":1774010998,"startTime":"0","endTime":"0","summary":"开立医疗(300633.SZ)公告称，公司近日取得招商银行深圳分行出具的《贷款承诺函》，同意为公司回购股份提供不超过1.8亿元的专项贷款，期限不超过36个月，用于回购公司股票，担保方式为信用。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000040285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","SG9999006597.SGD","BK0251","SG9999001051.SGD","300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620178649","title":"3月20日开立医疗创60日新低，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620178649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620178649?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:27","pubTimestamp":1773995230,"startTime":"0","endTime":"0","summary":"证券之星消息，3月20日开立医疗创60日新低，收盘报24.9元，当日跌2.73%，换手率1.07%，成交量2.87万手，成交额7245.68万元。重仓开立医疗的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。该公募基金现任基金经理为万民远。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","SG9999001051.SGD","BK0251","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778655234638,"stockEarnings":[{"period":"1week","weight":-0.0353},{"period":"1month","weight":-0.1106},{"period":"3month","weight":-0.1235},{"period":"6month","weight":-0.1942},{"period":"1year","weight":-0.2816},{"period":"ytd","weight":-0.1109}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0573},{"period":"3month","weight":0.02},{"period":"6month","weight":0.0459},{"period":"1year","weight":0.2509},{"period":"ytd","weight":0.0619}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳开立生物医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"18332人(较上一季度减少1.32%)","perCapita":"14618股","listingDate":"2017-04-06","address":"广东省深圳市南山区粤海街道麻岭社区高新中区科技中2路1号深圳软件园(2期)12栋201、202","registeredCapital":"43271万元","survey":" 深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是超声诊断仪、消化与呼吸内镜、微创外科产品、心血管介入产品。","listedPrice":5.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开立医疗,300633,开立医疗股票,开立医疗股票老虎,开立医疗股票老虎国际,开立医疗行情,开立医疗股票行情,开立医疗股价,开立医疗股市,开立医疗股票价格,开立医疗股票交易,开立医疗股票购买,开立医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}